FAM122A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.4432899320127E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.51859999972548E-07 |
Normal-vs-Stage2 |
2.40280000000093E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
7.060400E-02 |
Stage1-vs-Stage3 |
5.29719601516376E-11 |
Stage1-vs-Stage4 |
1.11000098002023E-12 |
Stage2-vs-Stage3 |
1.018580E-01 |
Stage2-vs-Stage4 |
2.153800E-02 |
Stage3-vs-Stage4 |
2.272400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6269208202857E-12 |
Normal-vs-AfricanAmerican |
1.43429999999167E-06 |
Normal-vs-Asian |
1.663450E-01 |
Caucasian-vs-AfricanAmerican |
8.878200E-01 |
Caucasian-vs-Asian |
7.283200E-01 |
AfricanAmerican-vs-Asian |
7.329000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
4.73979999693341E-09 |
Male-vs-Female |
3.643200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.392240E-04 |
Normal-vs-Age(41-60Yrs) |
2.5043001006253E-10 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.20259999736305E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.958800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.642800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.099800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.353900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.189560E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.218000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.690600E-01 |
Normal-vs-Grade 2 |
1.6194599999908E-05 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
9.277900E-02 |
Grade 1-vs-Grade 3 |
1.70809999999744E-06 |
Grade 1-vs-Grade 4 |
6.19250000166716E-08 |
Grade 2-vs-Grade 3 |
3.59480223366404E-11 |
Grade 2-vs-Grade 4 |
1.8428591985753E-12 |
Grade 3-vs-Grade 4 |
1.835140E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.373000E-04 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
3.54389850798498E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.76991754585742E-12 |
Normal-vs-N1 |
3.08164604945205E-12 |
N0-vs-N1 |
4.796000E-03 |
|
|